Skip to content

TOOP

Active
Private limited company (pre-2019)founded 2019active for 7 yearsMechelsestraat 29, 3000 Leuven, BelgiumKBO/BCE: BE 0723.540.717
Summary

TOOP has been active since 2019 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €56,308 and a net result of €2,446. Equity is growing by about 4.7% per year across the filed financial years. Its solvency ranks better than 23% of 2,939 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).

Overview

Activity
Medical imaging and medical laboratories
NACE 86910Retail sale of prescription glasses, lenses and sunglasses NACE 47742
1 site
Size
€239,284total assets 2025
Staff
2.8 FTE
Equity
€56,308
Profit
€2,446
Turnover not published (abbreviated or micro format)
Financial health
83 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.3%
Structure
Holdings
1
Accounts 17 days early0 of 2 deeds read
Why 83raises riskLiquidity: current ratio 0.91, cash €2,801Size: 2.8 FTE, total assets €239,284lowers riskSector: Human health activities (NACE 86)Figures for financial year 2025 (filed 14-07-2026)Show the evidence

Checked score

Score 2025
83 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 20% of its sector peers (NACE 86, micro)
Financial strength · tick = 2024
Weak
Solvency 49-4
equity 23.5% of total assets
Liquidity 12-11
short-term debt 73.3% · cash 1.2%
Profitability 70+6
return on assets 1.0%
Bankruptcy probability, 12 months
0.3% Very low
0%0.5%1.5%4%10%≥ 25%

About 3 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,042 companies, NACE 86, micro)
Last 24 months 11-2024: 0.1%lowest value 12-2024: 0.1%● unchanged vs 11-2024lowest value 01-2025: 0.1%● unchanged vs 12-2024lowest value 02-2025: 0.1%● unchanged vs 01-2025lowest value 03-2025: 0.2%▲ +0.1 percentage points vs 02-2025 04-2025: 0.2%● unchanged vs 03-2025 05-2025: 0.2%● unchanged vs 04-2025 06-2025: 0.2%● unchanged vs 05-2025 07-2025: 0.2%● unchanged vs 06-2025 08-2025: 0.3%▲ +0.1 percentage points vs 07-2025 09-2025: 0.3%● unchanged vs 08-2025 10-2025: 0.3%● unchanged vs 09-2025 11-2025: 0.3%● unchanged vs 10-2025 12-2025: 0.3%● unchanged vs 11-2025 01-2026: 0.3%● unchanged vs 12-2025 02-2026: 0.3%● unchanged vs 01-2026 03-2026: 0.4%▲ +0.1 percentage points vs 02-2026 04-2026: 0.4%● unchanged vs 03-2026highest value 05-2026: 0.4%● unchanged vs 04-2026 06-2026: 0.4%● unchanged vs 05-2026 07-2026: 0.4%● unchanged vs 06-2026 08-2026: 0.3%▼ -0.1 percentage points vs 07-2026 09-2026: 0.3%● unchanged vs 08-2026 10-2026: 0.3%● unchanged vs 09-2026
Credit of up to €4,500 on 30-day terms is acceptable
Liquidity insufficient (current ratio 0.91, compared with 1.14 in 2024; short-term debt: 73.3% and cash: 1.2% of total assets), and 76.5% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 22% on solvency, 2% on liquidity, 14% on profitability and 44% on growth.

The bankruptcy probability was computed on 12-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
raises risk · Liquidity: current ratio 0.91, cash €2,801
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed 14-07-2026)
NBB · annual accounts
raises risk · Size: 2.8 FTE, total assets €239,284
Companies of this size fail more often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 23% of 2939 sector peers (2025).
NBB · sector comparison
Position among 2939 sector peers
Solvency
better than 23%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 14-07-2026, 17 days ahead of the deadline.
NBB · 7 filings
Deviation from the deadline
2025
17 days early
2024
30 days early
2023
50 days early
2022
11 days early
2021
26 days late
2020
33 days early
2019
29 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 21 days before the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 14 July (4 of the last 5 filed years within 32 days of that day).
Companies Code · seven months
Where today falls in the filing period
12-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · abbreviated…
  2. Annual accounts filedfinancial year 2024 · abbreviated…
  3. Annual accounts filedfinancial year 2023 · abbreviated…

Key points

  • Caution: Among the weakest 12% on net resultsector median €112,640 · 2,905 companies €2,446 View
  • Positive: Filed on time since financial year 2022accounts within the deadline every year 4 years View
  • Total assets 20256 financial years filed €239,284 View

By topic

Financials

Financial year
2025
Total assets
€239,284
Profit
€2,446
Solvency
23.5%
Total assets▲ 21.1%
Net result
20192025
Go to Financials

Timeline

Events
10
Since
2020
Next accounts
by 31-07-2027
  1. 31-12-2023Back to profit
  2. 20-07-2023Annual accounts filed
  3. 31-12-2022Weakest financial year
Go to Timeline

Company details

Sites
1
Legal form
Private limited company (pre-2019)
Activity
Medical imaging and medical laboratoriesNACE 86910
Founded
25-03-2019
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.